Trends in Chemical & Pharmaceutical Research
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal...
View ArticleThe Winning Formula
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal...
View ArticleExperts Statements: Prof. Jochen Maas, Sanofi-Aventis Deutschland
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal...
View ArticleBayer Sees Sharp Growth in Chinese Medical Market
German drug and chemical maker Bayer expects China's medical market to grow nearly 10-fold over the next decade as the country aims to overhaul its medical system, a top executive said on Tuesday. read...
View ArticleWhite Knight Could Be Elusive For Genzyme
Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid for the biotechnology...
View ArticleSanofi's Best Bet Still May Be Smaller Deals
Sanofi-Aventis has grabbed the headlines with its $18.4 billion bid for Genzyme, but the French drugmaker may be wiser to stick with smaller, bolt-on acquisitions. Sanofi is trying to balance the need...
View ArticleGenzyme Has Little Leverage To Play Hardball
Biotechnology company Genzyme may be holding out for more money from suitor Sanofi-Aventis,but will find it difficult to persuade investors it is better off on its own. France's Sanofi has offered $69...
View ArticleEuropean Staff Fight Back As Drugmakers Hack Costs
Europe's pharmaceuticals industry, not known for industrial disputes, is experiencing a spate of clashes as employees fight back against cuts in jobs and benefits. Britain's second-biggest drugmaker,...
View ArticleGenzyme, Sanofi Silence May Indicate Talks
The lack of new information about Sanofi Aventis' reported interest in acquiring Genzyme could mean the two sides have begun talks, according to Sanford Bernstein analyst Geoffrey Porges. "The best...
View ArticleAntitrust Probe in the EU Pharma Sector
EU anti-trust regulators have carried out raids on some firms in the pharmaceutical sector on suspicions of collusion to delay the entry of generic drugs into the market, the European Commission said...
View Article
